- Home
- CORT
as 03-28-2025 4:00pm EST
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 7.1B | IPO Year: | N/A |
| Target Price: | $99.75 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.23 | EPS Growth: | 30.85 |
| 52 Week Low/High: | $20.84 - $75.00 | Next Earning Date: | 04-30-2025 |
| Revenue: | $675,040,000 | Revenue Growth: | 39.94% |
| Revenue Growth (this year): | 36.81% | Revenue Growth (next year): | 29.94% |
Stock Insider Trading Activity of Corcept Therapeutics Incorporated (CORT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas | CORT | See Remarks | Mar 24 '25 | Sell | $60.58 | 421 | $25,504.18 | 9,009 | |
| Swisher Daniel N JR | CORT | Director | Mar 10 '25 | Sell | $53.60 | 2,200 | $117,920.00 | 0 | |
| Lyon Joseph Douglas | CORT | See Remarks | Feb 28 '25 | Sell | $60.69 | 4,579 | $277,901.80 | 9,009 | |
| Maduck Sean | CORT | See Remarks | Feb 28 '25 | Sell | $60.69 | 18,303 | $1,110,818.22 | 85,622 | |
| Guyer William | CORT | Chief Development Officer | Feb 28 '25 | Sell | $59.07 | 20,000 | $1,181,400.00 | 5,487 | |
| BELANOFF JOSEPH K | CORT | Chief Executive Officer | Feb 28 '25 | Sell | $60.91 | 2,924 | $178,097.92 | 3,019,411 | |
| Swisher Daniel N JR | CORT | Director | Feb 10 '25 | Sell | $68.08 | 2,200 | $149,776.00 | 0 | |
| Lyon Joseph Douglas | CORT | See Remarks | Feb 3 '25 | Sell | $66.92 | 5,000 | $334,600.00 | 9,009 | |
| Maduck Sean | CORT | See Remarks | Feb 3 '25 | Sell | $66.92 | 20,000 | $1,338,400.00 | 85,622 | |
| Swisher Daniel N JR | CORT | Director | Jan 10 '25 | Sell | $50.54 | 2,200 | $111,188.00 | 0 |
Latest Corcept Therapeutics Incorporated News
CORT Breaking Stock News: Dive into CORT Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
3 Reasons to Sell CORT and 1 Stock to Buy Instead
Argus Research
4 days ago
CORT: Raising target price to $76.00
Zacks
8 days ago
Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?
StockStory
10 days ago
3 Growth Stocks in Hot Water
StockStory
15 days ago
1 Small-Cap Stock on Our Buy List and 2 to Avoid
Simply Wall St.
18 days ago
Top Growth Companies With Significant Insider Ownership
Business Wire
19 days ago
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
Zacks
22 days ago
Corcept Shares Rise More Than 55% in 6 Months: Here's Why
Compare CORT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CORT Corcept Therapeutics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.